Polyrizon Ltd.

Stage 4 · Declining · week 7

As of Oct 22, 2026, Polyrizon is in Stage 4, the downtrend phase, now in week 7 (since Sep 3, 2026). It closed at $8.72, 49.2% below its 52-week high and below its 200-day average, which is falling.

Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. More about the company

$8.72

-5.22% today

$21.2M · Micro cap

Market Neutral — Building

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Steady

Edge

—

Is PLRZ early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2024-10-29 → 2026-10-22

S? 42w

S1 10w

S2 10w

2024-10-292026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S? 42w → S4 1w → S1 7w → S4 8w → S1 10w → S2 7w → S3 4w → S2 10w → S3 6w → S4 7w current

Total tracked: 103 weeks across 10 stage runs.

PLRZ among Biotechnology122nd of 591 by relative strength

All 591 →

Stocks in Biotechnology ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	GTBPGT Biopharma, Inc.	Stage 2 · wk 7	99	−22.3%
2	IOVAIovance Biotherapeutics, Inc.	Stage 2 · wk 18	99	+38.8%
3	SLSSELLAS Life Sciences Group, Inc.	Stage 3 · wk 4	99	−1.5%
4	MRNAModerna, Inc.	Stage 2 · wk 17	99	+11.3%
5	TWSTTwist Bioscience Corporation	Stage 2 · wk 39	99	−14.5%
6	KODKodiak Sciences Inc	Stage 2 · wk 4	99	+172.1%
7	ERASErasca, Inc.	Stage 3 · wk 5	99	+0.7%
8	CLYMClimb Bio, Inc.	Stage 3 · wk 3	99	−15.8%
…122	PLRZPolyrizon Ltd.	Stage 4 · wk 7	75	−21.9%

vs 52W High

-49.2%

$3.13 lo$17.17 hi

49.2% below 52W high, deep Stage 4 damage

In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.

Stage Maturity

Week 7

1w13w26w

Week 7, early Stage 4 decline

How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.

vs 200 DMA

-31.7%

200 DMA: $12.77 · sloping down

In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.

Rel Volume

0.06x

vs 50-day avg

High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.

Trend Health

↓

Short-term trend rolling over

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

-21.9%

-40.6%

-41.0%

YTD

-31.6%

+27.5%

Scan Membership

Not in any current scan.

Recent Stage Timeline

2026-10-22S4

Wk 7 · Vol 0.06x

2026-10-21S4

Wk 7 · Vol 0.11x

2026-10-20S4

Wk 7 · Vol 0.28x

2026-10-19S4

Wk 7 · Vol 0.46x

2026-10-16S4

Wk 7 · Vol 0.34x

2026-10-15S4

Wk 6 · Vol 1.30x

2026-10-14S4

Wk 6 · Vol 1.53x

2026-10-13S4

Wk 6 · Vol 0.78x

2026-10-12S4

Wk 6 · Vol 0.10x

2026-10-09S4

Wk 6 · Vol 0.65x

2026-10-08S4

Wk 5 · Vol 0.17x

2026-10-07S4

Wk 5 · Vol 0.08x

Moving averages & range

50 DMA

$10.73

200 DMA

$12.77

52W High

$17.17

52W Low

$3.13

5D Low

$8.72

Resistance levels (recent highs)

20d High

$10.78

60d High

$14.51

120d High

$17.17

250d High

$17.17

Next resistance

+23.7%

to 20d High

ROE

-21.4%

Profit margin 0.0%

Dividend Yield

0.00%

P/B 0.8

Polyrizon: quick answers

What stage is Polyrizon in?

As of Oct 22, 2026, Polyrizon (PLRZ) is in Stage 4, the downtrend phase. It entered Stage 4 on Sep 3, 2026 and is in week 7. What the four stages mean

Is Polyrizon in an uptrend?

No. Polyrizon is in a Stage 4 downtrend. It trades 31.7% below its 200-day average, which is falling.

How far is Polyrizon from its 52-week high?

Polyrizon closed at $8.72 on Oct 22, 2026, 49.2% below its 52-week high of $17.17. Its 52-week low is $3.13.

How has Polyrizon performed over the past year?

As of Oct 22, 2026, Polyrizon is up 27.5% over the past year and down 31.6% so far in 2026.

Which sector and industry is Polyrizon in?

Polyrizon is in the Biotechnology industry, part of the Health Care sector.

About this companyHealth Care· Biotechnology

Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company uses its proprietary technology to develop its products comprising Capture and Contain, a barrier against a range of allergen particulates and viruses; and Trap and Target for nasal delivery of active pharmaceutical ingredients. It also develops PL-14, a nasal allergies blocker; and PL-16 for influenza blockers. Polyrizon Ltd. was incorporated in 2005 is headquartered in Ra'anana, Israel.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.